
Say what?





A concerned citizen contacted the Center for Disease Control (CDC) in Atlanta, GA yesterday and spoke to multiple employees. When asked if the CDC was mandating its employees to inject themselves with the experimental gene therapy called a ‘vaccine’ for the CCP virus, they pushed back, got defensive, and finally said no, they are not mandating CDC employees receive the ‘vaccine’ for Covid-19, which has not even been tested on animals and is still experimental, under an emergency use authorization only.
You can listen to the conversation on the video below. The hypocrisy is mind-blowing.
The citizen also spoke to supervisors who simply ‘expedited’ the call to nowhere and would not answer further questions.
The University of California San Diego Health appears to be the latest health care system to require badge tags for employees stating whether or not they have been vaccinated against COVID-19.
In an Aug. 2 internal memo released anonymously to The Epoch Times, UCSD Health stated, “given the current environment,” the badge tags are an important update to COVID-19 protocols.
According to the memo, the badge tags will provide a “visual cue regarding a team member’s vaccination status,” and will be available this week for all vaccinated employees.
“There will also be a special thank you to recognize all employees for your hard work,” the memo added.
Obtaining a badge tag will require proof of vaccination, the memo added. However, if employees don’t have any vaccine verifications, “we will evaluate CDC vaccine cards on a case-by-case basis.”
The badge tag is tamperproof and will be attached to an employee’s ID to show vaccination status.
Under the new protocols, unvaccinated health care workers will be required to wear N95 masks “in all areas of health care” while under strict enforcement.

A new study has found that individuals that have previously contracted COVID-19 show a more potent antibody response than those who were solely vaccinated for the respiratory virus.
Conducted by a research team at Rockefeller University in New York, the analysis found “that between a first (prime) and second (booster) shot of either the Pfizer-BioNTech or Moderna vaccine, the memory B cells of infection-naïve individuals produced antibodies that evolved increased neutralizing activity against SARS-CoV-2,” but also that “no additional increase in the potency or breadth of this activity was observed thereafter.”
Meanwhile, researchers determined that not only do recovered COVID-19 patients possess neutralizing antibodies up to a year after infection, but that such infection simultaneously assists in offering protection against developing variants.
“Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection produces B-cell responses that continue to evolve for at least one year,” the study read. “During that time, memory B cells express increasingly broad and potent antibodies that are resistant to mutations found in variants of concern.”
The analysis later goes on to conclude, “Memory antibodies selected over time by natural infection have greater potency and breadth than antibodies elicited by vaccination.”

The potentially serious heart disorders of pericarditis, inflammation of the heart’s surrounding membrane; and myocarditis, inflammation of the heart muscle, are happening after Covid-19 vaccination substantially more often than previously reported.
That’s according to new research led by Dr. George Diaz, Section of Infectious Diseases, Providence Regional Medical Center Everett, Everett, Washington; published in the Journal of the American Medical Association (JAMA).
Diaz and his co-authors reviewed electronic medical hospital records of more than 2 million people who received at least one Covid-19 vaccination. They found 37 cases of vaccine-related pericarditis and 20 cases of vaccine-related myocarditis. That’s still “rare,” but far more than what was expected had Centers for Disease Control’s (CDC’s) numbers from the Vaccine Adverse Event Reporting System (VAERS) been accurate.
According to CDC, myocarditis was reported to the VAERSS at a rate of about 4.8 cases per million, or less than 1/2 per 100,000 (.48 per 100,000). The disorder was reportedly lumped in together with pericarditis in the VAERS reporting analyzed by CDC.
But the new analysis unearthed a rate of 1.8 per 100,000 people for pericarditis and 1 in 100,000 for myocarditis. That’s a combined rate that’s more five times higher than thought: 2.8 people per 100,000 rather than 1/2 per 100,000.
The information seems to confirm what scientists have long said has long been well-established: there is a significant underreporting of adverse event reports to the federal VAERS system. Therefore, each report of an illness is presumed to be more prevalent than what’s documented through VAERS.
You must be logged in to post a comment.